EUVIMEDEUVIMED entdecken
Übersichtsarbeit

MicroRNAs target the PI3K/Akt/p53 and the Sirt1/Nrf2 signaling pathways in doxorubicin‐induced cardiotoxicity

Fatemeh Yarmohammadi, Zainab Ebrahimian, Gholamreza Karimi

Journal of Biochemical and Molecular Toxicology · 2023-02 · 37 (2)

DOI: 10.1002/jbt.23261 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 23.11.2022. Verfasst von Fatemeh Yarmohammadi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Cardiotoxicity, MicroRNAs. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 81 Literaturangaben. Gefördert von: Mashhad University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Doxorubicin (DOX) is used as a chemotherapeutic agent in the treatment of solid tumors. Irreversible cardiotoxicity is the major limitation in the clinical use of DOX. Several microRNAs (miRNAs) with diversified functions are identified that participate in exacerbating or suppressing DOX‐induced cardiac damage. The miRNAs are small noncoding regulatory RNAs that modify the expression of the native genes. Studies have demonstrated that miRNAs by modifying the expression of proteins such as PTEN, Akt, and survivin can affect DOX‐induced cardiac apoptosis. Moreover, miRNAs can modulate cardiac oxidative stress in DOX treatment through the posttranscriptional regulation of Sirt1, p66shc, and Nrf2 expressions. This manuscript has reviewed the regulation of the PI3K/Akt/p53 and the Sirt1/Nrf2 pathways by miRNAs in DOX‐induced cardiotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiotoxicityMicroRNAsHumansSrc Homology 2 Domain-Containing, Transforming Protein 1Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesNF-E2-Related Factor 2Tumor Suppressor Protein p53Sirtuin 1DoxorubicinSignal TransductionApoptosisOxidative StressMyocytes, Cardiac

Stichwörter der Autor:innen

cardiac injurymicroRNA overexpressionmicroRNA suppressionphosphatase and tensin homologsurvivin

Substanzen

SHC1 protein, humanSrc Homology 2 Domain-Containing, Transforming Protein 1MicroRNAsProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesNF-E2-Related Factor 2Tumor Suppressor Protein p53Sirtuin 1DoxorubicinSIRT1 protein, human

Autor:innen und Institutionen

  • Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.

Förderung

  • Mashhad University of Medical Sciences

Zitieren

APA

Yarmohammadi, F., Ebrahimian, Z., & Karimi, G. (2023). MicroRNAs target the PI3K/Akt/p53 and the Sirt1/Nrf2 signaling pathways in doxorubicin‐induced cardiotoxicity. Journal of Biochemical and Molecular Toxicology, 37(2). https://doi.org/10.1002/jbt.23261

Vancouver

Yarmohammadi F, Ebrahimian Z, Karimi G. MicroRNAs target the PI3K/Akt/p53 and the Sirt1/Nrf2 signaling pathways in doxorubicin‐induced cardiotoxicity. Journal of Biochemical and Molecular Toxicology. 2023;37(2). doi:10.1002/jbt.23261

BibTeX
@article{Yarmohammadi2023,
  author = {Yarmohammadi, Fatemeh and Ebrahimian, Zainab and Karimi, Gholamreza},
  title = {MicroRNAs target the PI3K/Akt/p53 and the Sirt1/Nrf2 signaling pathways in doxorubicin‐induced cardiotoxicity},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2023},
  volume = {37},
  number = {2},
  doi = {10.1002/jbt.23261}
}
Kostenlos starten →